Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
NCT ID: NCT00269542 Phase: NA Status: COMPLETED Enrollment: 94359 Completion: 2003-08
Conditions
Morbidity, Mortality, Diarrhea, Pneumonia
Interventions
Zinc and iron folic acid - Intervention, Iron Folic Acid alone - Placebo
Summary
Children, aged 1 months to 23 months, in the intervention households received zinc, iron and folic acid and those in the control households were administered iron and folic acid (IFA) alone for a period of one year. The primary outcomes were hospitalizations and deaths during this period.
Primary Outcome
- to determine the impact of daily oral supplementation of zinc (5 mg per day to infants aged less than 6 months and 10 mg per day to older children) and iron folic acid to children aged 1-23 months for a period of upto 12 months on all-cause mortality,